|
|
Vol. 13.17 – 20 June, 2024
|
|
|
|
|
|
|
|
Researchers presented data from ROS proto-oncogene 1 (ROS1)-positive cohort. Patients ≥18 years of age with stage IIIB/IV, ROS1-positive NSCLC detected by liquid biopsies received entrectinib 600 mg daily. [Nature Medicine]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Transcriptome analysis revealed that R. delemar infection induces the expression of many pro-inflammatory genes whose expression was significantly reduced by hypoxia inducible factor 1-alpha inhibition.
[Nature Communications]
|
|
|
|
|
|
Scientists reported a CD44high subpopulation of alveolar type II stem cells characterized by increased expression of genes that regulated immune signaling even during steady-state homeostasis.
[Stem Cell Reports]
|
|
|
|
|
|
Investigators delved into the nuanced molecular interplay of cellular interactions in idiopathic pulmonary fibrosis (IPF), thereby laying the groundwork for innovative therapeutic approaches in the clinical field of IPF.
[Journal of Cellular and Molecular Medicine]
|
|
|
|
|
|
|
|
Using RNA-seq and metabolomics data from human NSCLC, the authors uncovered that LKB1 loss enhanced serine–glycine-one-carbon metabolism via serine hydroxymethyltransferase.
[Nature Metabolism]
|
|
|
|
|
|
Investigators demonstrated that genetic suppressor element 1 (GSE1) expression was aberrantly upregulated in lung adenocarcinoma and that GSE1 depletion inhibited the proliferation and migration of both A549 and H1299 cells. [Cell Biology International]
|
|
|
|
|
|
|
|
PubMed and Web of Science were searched from January 2018 to December 2023 for publications with key words of environmental pollutants, respiratory disorders, and extracellular vesicles.
[Thorax]
|
|
|
|
|
|
The authors review the existing literature on the signaling pathways linked to the pathogenesis of idiopathic pulmonary fibrosis, both within national and international contexts. [Respiratory Research]
|
|
|
|
|
|
|
|
A five-year, $18.5 million grant will allow University of Alabama at Birmingham (UAB) researchers to investigate T and B tissue-resident memory cells in transplanted lungs, kidneys and uteruses of UAB patients. [University of Alabama at Birmingham]
|
|
|
|
|
|
|
|
July 10-13, 2024 Hamburg, Germany
|
|
|
|
|
|
|
|
|
|
|
Cedars-Sinai – Los Angeles, California, United States
|
|
|
|
|
|
|
KU Leuven – Leuven, Belgium
|
|
|
|
|
|
|
Uppsala University – Uppsala, Sweden
|
|
|
|
|
|
|
Cedars-Sinai – Los Angeles, California, United States
|
|
|
|
|
|
|
Cedars-Sinai – Los Angeles, California, United States
|
|
|
|
|
|